Cardinal Health has announced plans to purchase US manufacturer and distributor of extravascular closure devices, AccessClosure, in June 2014, subject to regulatory clearance. AccessClosure’s Mynx family of vascular closure devices helps physicians seal the femoral artery using a secure sealant, which dissolves within 30 days.
Shaden Marzouk, vice president clinical affairs for Cardinal Health, notes: “This acquisition will create a platform for an interventional suite offering that is differentiated in the marketplace.”
Cardinal Health provides pharmaceuticals and medical products and services and is also the industry-leading direct-to-home medical supplies distributor. It is also a manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products.
Founded in 2002, AccessClosure is a privately-held medical device company pioneering products designed to address complex challenges in the cardiovascular and peripheral vascular markets.